UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacokinetics and pharmacodynamics of nab-paclitaxel in patients with solid tumors: Disposition kinetics and pharmacology distinct from solvent-based paclitaxel

Journal of clinical pharmacology, 2014-10, Vol.54 (10), p.1097-1107

2014

Volltextzugriff (PDF)

Brivaracetam Disposition in Renal Impairment

Journal of clinical pharmacology, 2012-12, Vol.52 (12), p.1927-1933

2012

Volltextzugriff (PDF)

Characterizing the Nonlinear Pharmacokinetics and Pharmacodynamics of BI 187004, an 11β‐Hydroxysteroid Dehydrogenase Type 1 Inhibitor, in Humans by a Target‐Mediated Drug Disposition Model

Journal of clinical pharmacology, 2024-08, Vol.64 (8), p.993-1005

2024

Volltextzugriff (PDF)

CYP2B66 Genotype Specific Differences in Artemether‐Lumefantrine Disposition in Healthy Volunteers

Journal of clinical pharmacology, 2020-03, Vol.60 (3), p.351-360

2020

Volltextzugriff (PDF)

Disposition kinetics and metabolism of nicotine and cotinine in African American smokers: impact of CYP2A6 genetic variation and enzymatic activity

Pharmacogenetics and genomics, 2016-07, Vol.26 (7), p.340-350

2016

Volltextzugriff (PDF)

Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants

Pharmacogenetics and genomics, 2007-08, Vol.17 (8), p.647-656

2007

Volltextzugriff (PDF)

Population Pharmacokinetic Analysis of Alirocumab in Healthy Volunteers or Hypercholesterolemic Subjects Using a Michaelis–Menten Approximation of a Target-Mediated Drug Disposition Model—Support for a Biologics License Application Submission: Part I

Clinical pharmacokinetics, 2019-01, Vol.58 (1), p.101-113

2019

Volltextzugriff (PDF)

Disposition of soy isoflavones in normal human breast tissue

The American journal of clinical nutrition, 2010-04, Vol.91 (4), p.976-984

2010

Volltextzugriff (PDF)

Drug disposition and modelling before and after gastric bypass: immediate and controlled‐release metoprolol formulations

British journal of clinical pharmacology, 2015-11, Vol.80 (5), p.1021-1030

2015

Volltextzugriff (PDF)

Human disposition, metabolism and excretion of etamicastat, a reversible, peripherally selective dopamine β‐hydroxylase inhibitor

British journal of clinical pharmacology, 2014-06, Vol.77 (6), p.1017-1026

2014

Volltextzugriff (PDF)

The effect of liver dysfunction on the pharmacokinetic disposition of belinostat and its five metabolites in patients with advanced cancers

Cancer chemotherapy and pharmacology, 2024-08, Vol.94 (2), p.157-167

2024

Volltextzugriff (PDF)

Interaction between ABCG2 421C>A polymorphism and valproate in their effects on steady‐state disposition of lamotrigine in adults with epilepsy

British journal of clinical pharmacology, 2018-09, Vol.84 (9), p.2106-2119

2018

Volltextzugriff (PDF)

Effect of Rifampin on the Disposition of Brivaracetam in Human Subjects: Further Insights into Brivaracetam Hydrolysis

Drug metabolism and disposition, 2016-06, Vol.44 (6), p.792-799

2016

Volltextzugriff (PDF)

Pulmonary Disposition of Tedizolid following Administration of Once-Daily Oral 200-Milligram Tedizolid Phosphate in Healthy Adult Volunteers

Antimicrobial Agents and Chemotherapy, 2012-05, Vol.56 (5), p.2627-2634

2012

Volltextzugriff (PDF)

Brivaracetam Disposition in Mild to Severe Hepatic Impairment

Journal of clinical pharmacology, 2013-06, Vol.53 (6), p.633-641

2013

Volltextzugriff (PDF)

The metabolism and disposition of GSK2140944 in healthy human subjects

Xenobiotica, 2016-08, Vol.46 (8), p.683-702

2016

Volltextzugriff (PDF)

Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe

Pharmacogenetics and genomics, 2008-05, Vol.18 (5), p.439-448

2008

Volltextzugriff (PDF)

Toward systems-informed models for biologics disposition: covariates of the abundance of the neonatal Fc Receptor (FcRn) in human tissues and implications for pharmacokinetic modelling

European journal of pharmaceutical sciences, 2023-03, Vol.182, p.106375, Article 106375

2023

Volltextzugriff (PDF)

Population Pharmacokinetics as a Tool to Reevaluate the Complex Disposition of Ethanol in the Fed and Fasted States

Journal of clinical pharmacology, 2023-06, Vol.63 (6), p.681-694

2023

Volltextzugriff (PDF)

Target‐Mediated Drug Disposition Pharmacokinetic/Pharmacodynamic Model‐Informed Dose Selection for the First‐in‐Human Study of AVB‐S6‐500

Clinical and translational science, 2020-01, Vol.13 (1), p.204-211

2020

Volltextzugriff (PDF)

Mass balance, metabolic disposition, and pharmacokinetics of a single oral dose of regorafenib in healthy human subjects

Cancer chemotherapy and pharmacology, 2018-01, Vol.81 (1), p.195-206

2018

Volltextzugriff (PDF)

Disposition of cannabinoids and their metabolites in serum, oral fluid, sweat patch and urine from healthy individuals treated with pharmaceutical preparations of medical cannabis

Phytotherapy research, 2021-03, Vol.35 (3), p.1646-1657

2021

Volltextzugriff (PDF)

Alterations in drug disposition during pregnancy: implications for drug therapy

Expert opinion on drug metabolism & toxicology, 2007-08, Vol.3 (4), p.557-571

2007

Volltextzugriff (PDF)

Gastrointestinal and Systemic Disposition of Diclofenac under Fasted and Fed State Conditions Supporting the Evaluation of in Vitro Predictive Tools

Molecular pharmaceutics, 2017-12, Vol.14 (12), p.4220-4232

2017

Volltextzugriff (PDF)

Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast‐feeding

British journal of clinical pharmacology, 2006-02, Vol.61 (2), p.155-163

2006

Volltextzugriff (PDF)

1 – 25 von 3.714

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieBiopharmaceutics & Drug Disposition

Zeitschrift / SerieThe American Journal Of Emergency Medicine

ThemaChild

ThemaTreatment Outcome

ThemaAdult

ThemaPharmacokinetics

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.633)
Mit Volltextzugriff
(2.940)

Publikationsform

Artikel
(3.714)

Sprache

Englisch
(3.710)
Japanisch
(3)
Deutsch
(1)
Spanisch
(1)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

13 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(3.712)
Journals@Ovid Ovid Full Text
(2.156)
Wiley Online Library
(1.633)
Wiley Online Library
(1.396)
Ingenta
(1.271)
EZB Electronic Journals Library
(1.270)
IngentaConnect Journals
(1.028)
Springer Nature
(934)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(681)
Publisher website
(341)
Access via ScienceDirect (Elsevier)
(247)
Nexis Uni
(227)
Access via Taylor & Francis
(186)
Taylor & Francis
(141)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(119)
Nature Journals
(119)
Access via Taylor & Francis
(98)
Oxford journals
(91)
Oxford Journals 2020 Medicine
(74)
SAGE Journals Online
(48)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(31)

Menü

Weitere Dienste

Einstellungen

Pharmacokinetics and pharmacodynamics of nab-paclitaxel in patients with solid tumors: Disposition kinetics and pharmacology distinct from solvent-based paclitaxel

Brivaracetam Disposition in Renal Impairment

Characterizing the Nonlinear Pharmacokinetics and Pharmacodynamics of BI 187004, an 11β‐Hydroxysteroid Dehydrogenase Type 1 Inhibitor, in Humans by a Target‐Mediated Drug Disposition Model

CYP2B66 Genotype Specific Differences in Artemether‐Lumefantrine Disposition in Healthy Volunteers

Disposition kinetics and metabolism of nicotine and cotinine in African American smokers: impact of CYP2A6 genetic variation and enzymatic activity

Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants

Population Pharmacokinetic Analysis of Alirocumab in Healthy Volunteers or Hypercholesterolemic Subjects Using a Michaelis–Menten Approximation of a Target-Mediated Drug Disposition Model—Support for a Biologics License Application Submission: Part I

Disposition of soy isoflavones in normal human breast tissue

Drug disposition and modelling before and after gastric bypass: immediate and controlled‐release metoprolol formulations

Human disposition, metabolism and excretion of etamicastat, a reversible, peripherally selective dopamine β‐hydroxylase inhibitor

The effect of liver dysfunction on the pharmacokinetic disposition of belinostat and its five metabolites in patients with advanced cancers

Interaction between ABCG2 421C>A polymorphism and valproate in their effects on steady‐state disposition of lamotrigine in adults with epilepsy

Effect of Rifampin on the Disposition of Brivaracetam in Human Subjects: Further Insights into Brivaracetam Hydrolysis

Pulmonary Disposition of Tedizolid following Administration of Once-Daily Oral 200-Milligram Tedizolid Phosphate in Healthy Adult Volunteers

Brivaracetam Disposition in Mild to Severe Hepatic Impairment

The metabolism and disposition of GSK2140944 in healthy human subjects

Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe

Toward systems-informed models for biologics disposition: covariates of the abundance of the neonatal Fc Receptor (FcRn) in human tissues and implications for pharmacokinetic modelling

Population Pharmacokinetics as a Tool to Reevaluate the Complex Disposition of Ethanol in the Fed and Fasted States

Target‐Mediated Drug Disposition Pharmacokinetic/Pharmacodynamic Model‐Informed Dose Selection for the First‐in‐Human Study of AVB‐S6‐500

Mass balance, metabolic disposition, and pharmacokinetics of a single oral dose of regorafenib in healthy human subjects

Disposition of cannabinoids and their metabolites in serum, oral fluid, sweat patch and urine from healthy individuals treated with pharmaceutical preparations of medical cannabis

Alterations in drug disposition during pregnancy: implications for drug therapy

Gastrointestinal and Systemic Disposition of Diclofenac under Fasted and Fed State Conditions Supporting the Evaluation of in Vitro Predictive Tools

Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast‐feeding

Aktive Filter

Suchergebnisse filtern